-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Arl/gc/qGZNW0mXcasg+dMnbWqlickTiVzPnq0HVWcVTfTCdmW0T7rNmgNIaL7Ke wUeYS8TXYYAkL6aBdZ0R5Q== 0000901219-04-000047.txt : 20040525 0000901219-04-000047.hdr.sgml : 20040525 20040525130549 ACCESSION NUMBER: 0000901219-04-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040521 FILED AS OF DATE: 20040525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DREWS JURGEN CENTRAL INDEX KEY: 0001184419 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 04829313 BUSINESS ADDRESS: STREET 1: GANAISSANCE PHARMACEUTICALS INC STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 2037731450 FORMER NAME: FORMER CONFORMED NAME: DREWS JORGEN DATE OF NAME CHANGE: 20020829 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9410 KEY W AVE CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 9410 KEY WEST AVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 dre242.xml X0202 4 2004-05-21 0 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001184419 DREWS JURGEN 14200 SHADY GROVE ROAD ROCKVILLE MD 20850 1 0 0 0 Non-Employee Director Stock Option - Right to Buy 10.69 2004-05-21 4 A 0 48000 0 A 2014-05-21 Common Stock 48000.00 48000.00 D Vests in equal monthly installments for 36 months with first vesting date on June 21, 2004. By: Steven C. Mayer, Pursuant to Power of Attorney 2004-05-24 EX-24 2 poa-drews2003.txt POWER OF ATTORNEY POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the person whose signature appears below hereby constitutes and appoints James H. Davis, Steven C. Mayer or Alain Cappeluti, his true and lawful attorney-in-fact, with full power of substitution and resubstitution, to sign any and all instruments, certificates and documents that may be necessary, desirable or appropriate to be executed on behalf of himself, pursuant to Section 16 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act") and the regulations promulgated there under, with respect to any and all filings relating to Human Genome Sciences, Inc., and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act, or the Bylaws of the National Association of Securities Dealers, Inc., granting unto said attorney-in-fact full power and authority to do and perform each and every act and thing necessary, desirable or appropriate, fully to all intents and purposes as he might or could do in person, thereby ratifying and confirming all that said attorney-in-fact, or his substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney will remain in effect for as long as the undersigned is subject to the reporting requirements of Section 16 of the Exchange Act. IN WITNESS WHEREOF, this Power of Attorney has been signed as of the 16th day of October 2003. /s/ Jurgen Drews Jurgen Drews, M.D. STATE OF MARYLAND ) ) ss.: COUNTY OF MONTGOMERY ) On this 16th day of October, 2003, before me personally appeared Jurgen Drews, to me known and known to me to be the individual described herein, and who executed the foregoing certificate, and thereupon duly acknowledged to me that he executed the same. /s/ Rose Hadidian Notary Public My Commission Expires: July 20, 2005 -----END PRIVACY-ENHANCED MESSAGE-----